The SPTLC2 gene helps your body make sphingolipids, fatty molecules that support nerve cells and their protective covering. If the SPTLC2 gene does not work properly, abnormal lipid byproducts can build up and nerves may stop sending signals in the usual way. What this gene does can influence how your body senses pain, touch, and temperature. Some people with pathogenic variants in the SPTLC2 gene develop an inherited nerve condition with numbness, burning pain, weakness, balance problems, or foot injuries that are easy to miss.
What is a gene?
Genes are sections of DNA that carry information your cells use to make molecules or regulate processes throughout the body. Some genes provide the instructions for producing proteins, which are the parts of cells that do the work. Others mainly help determine when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
SPTLC2Gene function
What if the gene works
The SPTLC2 gene helps cells make sphingolipids, a group of fats that build cell membranes. These fats are especially important for nerve signaling, skin barrier function, and normal cell growth.
Risk
What if the gene does not work
Pathogenic variants in the SPTLC2 gene can cause hereditary sensory and autonomic neuropathy, often with numbness, pain loss, foot ulcers, and weakness. Milder or more severe variants can affect when symptoms start and how severe they become.
Treatment
What does that mean for your treatment
No SPTLC2-specific treatment or drug choice approach is currently established in clinical guidelines. Research in SPTLC2-related neuropathy is exploring whether L-serine supplementation can lower harmful lipid byproducts called deoxysphingolipids, but this remains investigational rather than standard care.
Conditions associated with SPTLC2
Gene function
What if the gene works
Your cells need a steady supply of certain fats to build membranes and pass signals. The SPTLC2 gene helps make an enzyme that starts this production line. When it works normally, cells can keep making sphingolipids, which support everyday cell structure and communication.
SPTLC2 helps your cells begin making sphingolipids, a group of fats used in many tissues. It carries out the opening step in this process, which helps set the pace for sphingolipid production.
Sphingolipids made with help from SPTLC2 become part of cell membranes, the thin outer layer around cells. They help membranes stay organized and work properly as cells grow, divide, and exchange materials.
These fats also act as signals that help cells respond to routine needs such as growth, energy balance, and everyday stress. Understanding SPTLC2 gene function helps explain how cells coordinate structure with communication.
What is a variant?
Genetic variants are small differences in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can more substantially change how a gene works and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SPTLC2 gene can alter the shape or behavior of part of an enzyme, which is central to how variants in the SPTLC2 gene affect cells. Some changes mildly reduce enzyme stability or activity, while more severe variants can redirect the enzyme to use the wrong building blocks and make unusual fats that build up inside cells. In people with disease linked variants, stronger functional disruption is often associated with earlier or more noticeable nerve problems.
How variants are linked to conditions
Pathogenic variants in the SPTLC2 gene cause hereditary sensory and autonomic neuropathy type 1C, a rare inherited nerve condition. This SPTLC2 gene condition is linked to gradual loss of feeling, burning or shooting pain, foot injuries that may go unnoticed, and sometimes weakness in the legs or hands. Most people with this diagnosis inherit the variant from a parent, although severity can vary within the same family.
A variant is not necessarily a diagnosis
Across the general population, genetic variants are common and are a normal feature of human biology. Most do not directly affect health and instead reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than proving a diagnosis, particularly when several genes and environmental influences also play a role. Still, in certain situations, one well-characterized variant in a particular gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce health risk related to the SPTLC2 gene. In families with a harmful SPTLC2 change, the gene variant itself is usually the main factor, and a doctor or genetic counselor can help explain what that may mean for personal risk.
Inheritance of SPTLC2 variants
For families asking about SPTLC2 inheritance, disease-causing variants in the SPTLC2 gene are usually passed down in an autosomal dominant pattern. That means a person with a pathogenic variant has a 50% chance of passing it on to each child, whether the child is a son or a daughter. In many families, the variant is seen across generations because one affected parent can pass it to a child. Each pregnancy carries the same chance independently.
What does my SPTLC2 result mean for my family?
For SPTLC2, the best-known family pattern is dominant, which means a result linked to disease can also be found in close relatives. Parents, brothers and sisters, and children may have the same gene change, even if symptoms are milder or started later. This can matter in families with numbness, burning pain, foot problems, or trouble sensing injuries.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the SPTLC2 gene, SPTLC2 genetic testing uses a blood or saliva sample so a lab can read the DNA code and check for variants. Results may confirm a diagnosis, support family testing, or show that no clearly relevant variant was found.
When should I consider getting a genetic test?
Consider testing for changes in the SPTLC2 gene if you or close relatives have a rare inherited nerve condition with numb feet, burning pain, loss of feeling, weakness, or repeated foot injuries and sores. Testing can help confirm whether SPTLC2 is the cause in some families.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains varies based on the condition and the kind of variant involved. Over time, many other factors also shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small inherited differences can change how the body handles a drug or how strongly it responds to it, so the same treatment may work well for one person but less well for another. This is a common part of normal human variation and can influence both benefit and the chance of side effects.
What is Pharmacogenetics?
Pharmacogenetics explores how differences in genes can shape a person’s response to medicines. It examines links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medications, genes may affect both how strongly a drug works and how the body processes it. This understanding can support more informed, individualized treatment decisions. If you want to learn more about this topic, you can read further in the LearnHub.
Drugs influenced by the SPTLC2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so questions about medications, side effects, or new symptoms are best discussed with your doctor.
History
Researchers first studied the pathway involving the SPTLC2 gene while working out how cells make sphingolipids, an important group of fats in the body. In the late 1990s and early 2000s, the enzyme complex was mapped in more detail, and SPTLC2 was recognized as one of its core parts. Building on this early work, scientists linked rare variants in the SPTLC2 gene to inherited nerve conditions, especially hereditary sensory and autonomic neuropathy type 1. That finding helped explain why some families developed progressive loss of sensation over time. Later research showed that certain variants can alter the balance of lipid products the enzyme makes, which sharpened understanding of how disease develops. Over time, descriptions became more precise as genetic studies connected older clinical observations with specific changes in the gene.